Erik T Valent

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Candida Albicans

Multiple Myeloma

Gene Expression

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of laboratory hematology

Journal of cell science

This page only lists publications with an associated author ORCID identifier.

Publications

Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H J van der Velden, Remco M Hoogenboezem, Bronno van der Holt, H Berna Beverloo, Erik T Valent, Michael Vermeulen, Francesca Gay, Annemiek Broijl, Herve Avet-Loiseau, Nikhil C Munshi, Pellegrino Musto, Phillipe Moreau, Sonja Zweegman, Niels W C J van de Donk, Pieter Sonneveld
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Yan-Ting Chen, Erik T Valent, Erik H van Beers, Rowan Kuiper, Stefania Oliva, Torsten Haferlach, Wee-Joo Chng, Martin H van Vliet, Pieter Sonneveld, Alessandra Larocca
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials. International journal of laboratory hematology (2021)
Miesje van der Stoel, Lilian Schimmel, Kalim Nawaz, Anne-Marieke van Stalborch, Annett de Haan, Alexandra Klaus-Bergmann, Erik T Valent, Duco S Koenis, Geerten P van Nieuw Amerongen, Carlie J de Vries, Vivian de Waard, Martijn Gloerich, Jaap Diederik van Buul, Stephan Huveneers
DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis. Journal of cell science 133 (3) (2020)